Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31,465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparing the outcomes of MR-based versus CT-based tumor delineation in locally advanced non-small cell lung cancer treated with hypo-fractionated radiotherapy and concurrent chemotherapy.
Zhang P, Ding S, Peng K, He H, Wang D, Zhou R, Wang B, Guo J, Liu H, Huang X, Xie C, Liu H, Qiu B. Zhang P, et al. Transl Lung Cancer Res. 2024 Nov 30;13(11):2890-2902. doi: 10.21037/tlcr-24-341. Epub 2024 Nov 6. Transl Lung Cancer Res. 2024. PMID: 39670014 Free PMC article.
Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase I Study.
Zhou R, Liu F, Zhang H, Wang D, Zhang P, Zheng S, Liu Y, Chen L, Guo J, Zou Y, Rong YM, Liu H, Qiu B. Zhou R, et al. Among authors: zhang p, zhang h. Clin Cancer Res. 2024 Jul 1;30(13):2719-2728. doi: 10.1158/1078-0432.CCR-23-3600. Clin Cancer Res. 2024. PMID: 38652815 Clinical Trial.
Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059).
Ai X, Zhang P, Xie X, Qiu B, Zhu Y, Zhao L, Xi M, Wu Y, Guo S, Guo J, Liu F, Wang D, Chen N, He Q, Hu Y, Liu M, Ding Z, Liu H. Ai X, et al. Among authors: zhang p. Cancer Med. 2023 Jul;12(14):15000-15010. doi: 10.1002/cam4.6136. Epub 2023 Jun 16. Cancer Med. 2023. PMID: 37326436 Free PMC article. Clinical Trial.
Correlation of Ktrans derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy.
Wang D, Liu S, Fu J, Zhang P, Zheng S, Qiu B, Liu H, Ye Y, Guo J, Zhou Y, Jiang H, Yin S, He H, Xie C, Liu H. Wang D, et al. Among authors: zhang p. J Immunother Cancer. 2024 Jun 23;12(6):e008574. doi: 10.1136/jitc-2023-008574. J Immunother Cancer. 2024. PMID: 38910009 Free PMC article.
Uniform single-crystal mesoporous metal-organic frameworks.
Lv Z, Lin R, Yang Y, Lan K, Hung CT, Zhang P, Wang J, Zhou W, Zhao Z, Wang Z, Zou J, Wang T, Zhao T, Xu Y, Chao D, Tan W, Yan B, Li Q, Zhao D, Li X. Lv Z, et al. Among authors: zhang p. Nat Chem. 2025 Jan 6. doi: 10.1038/s41557-024-01693-9. Online ahead of print. Nat Chem. 2025. PMID: 39762625
31,465 results
You have reached the last available page of results. Please see the User Guide for more information.